Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Memorial Day
Cannes Film Festival
Artificial Intelligence
Social Media
Donald Trump
Google
European Union
Stock Markets
Republican Party
Natural Disasters
Soccer
Infrastructure
Published • loading... • Updated

CDMO ReciBioPharm taps NewBiologix to bolster AAV offering

Summary by BioProcess International
As per the agreement, the ReciBioPharm’s have gained access to NewBiologix’s Xcell-Eng-HEK293 cell line.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
BioProcess InternationalBioProcess International

CDMO ReciBioPharm taps NewBiologix to bolster AAV offering

As per the agreement, the ReciBioPharm’s have gained access to NewBiologix’s Xcell-Eng-HEK293 cell line.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BioProcess International broke the news in on Monday, May 12, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal